Anti-tumoral activity of the Pan-HER (Sym013) antibody mixture in gemcitabine-resistant pancreatic cancer models.
Rabia E, Garambois V, Hubert J, Bruciamacchie M, Pirot N, Delpech H, Broyon M, Theillet C, Colombo PE, Vie N, Tosi D, Gongora C, Khellaf L, Jarlier M, Radosevic-Robin N, Chardès T, Pèlegrin A, Larbouret C.
Rabia E, et al. Among authors: colombo pe.
MAbs. 2021 Jan-Dec;13(1):1914883. doi: 10.1080/19420862.2021.1914883.
MAbs. 2021.
PMID: 33876707
Free PMC article.